File: '\\swfile\EmailIn\20260717 152900 Attachment News Release announcing Debenture Financing.docx'

UniDoc Announces Private Placement of

Convertible Debentures

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VANCOUVER, British Columbia, July 17, 2026 -- UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) ("UniDoc" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement offering of non-transferable unsecured convertible debentures ("Debentures") for aggregate gross proceeds of up to $100,000 (the "Offering").

The Debentures will mature and be repayable on the date that is two years from the date of issuance (the "Maturity Date") and bear interest at a rate of 6.0% per annum. The Company may, at its option, prepay all or any portion of the Debentures in cash prior to the Maturity Date.

Following the closing date and prior to the Maturity Date, if the Company completes one or more subsequent issuances and sales of securities by way of private placement or public offering, including common shares, unit subscription receipts, special warrants, or convertible debt (a "Future Financing Event"), the Company will have the right, at its option, to satisfy its obligation to repay the Debentures through the conversion of the Debentures into units ("Units"). Each Unit will consist of one common share and one common share purchase warrant (a "Warrant") at a price which equals the price per security (excluding any permitted discounts) issued in any one such Future Financing Event as selected by the Company in its sole discretion, provided that in no event shall the price per Unit be lower than the minimum price permitted under the policies of the Canadian Securities Exchange ("CSE").

If the Future Financing Event selected by the Company includes units comprised of shares and share purchase warrants, the Warrants will have the same exercise price and expiry date as the Warrants issued pursuant to such Future Financing Event. If the Future Financing Event selected by the Company does not include the issuance of warrants, the Warrants will have a term of three (3) years from the date of issuance and an exercise price equal to the market price of the Company's common shares at the time such Future Financing Event is announced.

The proceeds raised from the Offering are expected to be used for working capital and general corporate purposes.

The Debentures and any securities issuable upon conversion will be subject to a four-month statutory hold in accordance with applicable Canadian securities laws. Completion of the Offering is subject to certain conditions including receipt of all necessary corporate and regulatory approvals, including the CSE.

On Behalf of the Board of Directors,

Antonio Baldassarre

CEO, President & Director

UniDoc Health Corp.

About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF)

UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.

For further information, please contact:

UniDoc Investor Relations

Tel: +1 778.383.6731

Email: info@unidoctor.com

Matt Chatterton, Director Tel: +1 778.613.2082

Email: matt@unidoctor.com

Media Inquiries media@unidoctor.com

Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Forward-looking information includes, but is not limited to: statements regarding the completion of the Offering, the anticipated gross proceeds of the Offering, the intended use of proceeds of the Offering, the terms of the Debentures, including the Company's ability to prepay the Debentures, the occurrence of a Future Financing Event, the Company's ability to satisfy repayment obligations through the issuance of Units, the terms of any Units and Warrants issuable upon such repayment, and the receipt of all required regulatory approvals, including any approvals required by the CSE. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "anticipates", "anticipated" "expected" "intends" "will" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are from those expressed or implied by such forward-looking statements or forward-looking information subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different, including receipt of all necessary regulatory approvals. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

The CSE does not accept responsibility for the adequacy or accuracy of this release.